Natural Killer (NK) Cell Therapy Pipeline Research Report 2024: Comprehensive Insights About 100+ Companies and 185+ Pipeline Drugs
19 avr. 2024 07h35 HE
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) cell therapy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Natural Killer...
Hypertriglyceridemia Drug Pipeline Research Report 2023: Comprehensive Insights About 20+ Companies and Respective Pipeline Drugs
16 nov. 2023 07h23 HE
|
Research and Markets
Dublin, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The "Hypertriglyceridemia - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
FDA Approved Fibroblast Growth Factor Receptor FGFR Inhibitor Anticancer Drug Market Clinical Trials 2026
18 nov. 2021 05h36 HE
|
KuicK Research
Delhi, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026 Report Highlights: Global FGFR Inhibitors...
Outlook on the Fibroblast Growth Factor Receptor Inhibitor Drug Global Market to 2026 - Focus on Belvesra, Pemazyre and Truseltiq
16 août 2021 04h33 HE
|
Research and Markets
Dublin, Aug. 16, 2021 (GLOBE NEWSWIRE) -- The "Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity & Clinical Trials Insight 2026" report has been added to...
Global FGFR Fibroblast Growth Factor Receptor Inhibitor Drug Market Clinical Trials Report 2026
09 août 2021 08h30 HE
|
KuicK Research
DELHI, India, Aug. 09, 2021 (GLOBE NEWSWIRE) -- “Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity & Clinical Trials Insight 2026” Report Highlights: Global FGFR...